Cargando…

Systemic network analysis identifies XIAP and IκBα as potential drug targets in TRAIL resistant BRAF mutated melanoma

Metastatic melanoma remains a life-threatening disease because most tumors develop resistance to targeted kinase inhibitors thereby regaining tumorigenic capacity. We show the 2nd generation hexavalent TRAIL receptor-targeted agonist IZI1551 to induce pronounced apoptotic cell death in mutBRAF melan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Del Mistro, Greta, Lucarelli, Philippe, Müller, Ines, De Landtsheer, Sébastien, Zinoveva, Anna, Hutt, Meike, Siegemund, Martin, Kontermann, Roland E., Beissert, Stefan, Sauter, Thomas, Kulms, Dagmar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218484/ https://www.ncbi.nlm.nih.gov/pubmed/30416750 http://dx.doi.org/10.1038/s41540-018-0075-y

Ejemplares similares

Focal adhesion kinase plays a dual role in TRAIL resistance and metastatic outgrowth of malignant melanoma
por: Del Mistro, Greta, et al.
Publicado: (2022)

IgG-single-chain TRAIL fusion proteins for tumour therapy
por: Siegemund, Martin, et al.
Publicado: (2018)

Convergence of pathway analysis and pattern recognition predicts sensitization to latest generation TRAIL therapeutics by IAP antagonism
por: Vetma, Vesna, et al.
Publicado: (2020)

Computational models of melanoma
por: Albrecht, Marco, et al.
Publicado: (2020)

Anti-Apoptotic NF-κB and “Gain of Function” mutp53 in Concert Act Pro-Apoptotic in Response to UVB+IL-1 via Enhanced TNF Production
por: Müller, Ines, et al.
Publicado: (2015)

XIAP promotes melanoma growth by inducing tumour neutrophil infiltration
por: Daoud, Mila, et al.
Publicado: (2022)

Antitumor Activity of a Mesenchymal Stem Cell Line Stably Secreting a Tumor-Targeted TNF-Related Apoptosis-Inducing Ligand Fusion Protein
por: Marini, Irene, et al.
Publicado: (2017)

Using Regularization to Infer Cell Line Specificity in Logical Network Models of Signaling Pathways
por: De Landtsheer, Sébastien, et al.
Publicado: (2018)

Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells
por: Hutt, Meike, et al.
Publicado: (2018)

FALCON: a toolbox for the fast contextualization of logical networks
por: De Landtsheer, Sébastien, et al.
Publicado: (2017)

A 3D Organotypic Melanoma Spheroid Skin Model
por: Müller, Ines, et al.
Publicado: (2018)

Identification of New IκBα Complexes by an Iterative Experimental and Mathematical Modeling Approach
por: Konrath, Fabian, et al.
Publicado: (2014)

Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma
por: Bintener, Tamara, et al.
Publicado: (2023)

Development of a human three-dimensional organotypic skin-melanoma spheroid model for in vitro drug testing
por: Vörsmann, H, et al.
Publicado: (2013)

Modeling time delay in the NFκB signaling pathway following low dose IL-1 stimulation
por: Witt, Johannes, et al.
Publicado: (2011)

Analysing the Role of UVB-Induced Translational Inhibition and PP2Ac Deactivation in NF-κB Signalling Using a Minimal Mathematical Model
por: Witt, Johannes, et al.
Publicado: (2012)

Topological network measures for drug repositioning
por: Badkas, Apurva, et al.
Publicado: (2020)

Construction and contextualization approaches for protein-protein interaction networks
por: Badkas, Apurva, et al.
Publicado: (2022)

Expanding the Disease Network of Glioblastoma Multiforme via Topological Analysis
por: Badkas, Apurva, et al.
Publicado: (2023)

A Fab-Selective Immunoglobulin-Binding Domain from Streptococcal Protein G with Improved Half-Life Extension Properties
por: Unverdorben, Felix, et al.
Publicado: (2015)

A miR-137-XIAP axis contributes to the sensitivity of TRAIL-induced cell death in glioblastoma
por: Geng, Fenghao, et al.
Publicado: (2022)

EGFR-Targeted TRAIL and a Smac Mimetic Synergize to Overcome Apoptosis Resistance in KRAS Mutant Colorectal Cancer Cells
por: Möller, Yvonne, et al.
Publicado: (2014)

L-plastin Ser5 phosphorylation is modulated by the PI3K/SGK pathway and promotes breast cancer cell invasiveness
por: Machado, Raquel A. C., et al.
Publicado: (2021)

The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization
por: Kluger, Harriet M, et al.
Publicado: (2007)

Specific down-regulation of XIAP with RNA interference enhances the sensitivity of canine tumor cell-lines to TRAIL and doxorubicin
por: Spee, Bart, et al.
Publicado: (2006)

Heightened JNK Activation and Reduced XIAP Levels Promote TRAIL and Sunitinib-Mediated Apoptosis in Colon Cancer Models
por: Mahalingam, Devalingam, et al.
Publicado: (2019)

Mechanistically Coupled PK (MCPK) Model to Describe Enzyme Induction and Occupancy Dependent DDI of Dabrafenib Metabolism
por: Albrecht, Marco, et al.
Publicado: (2022)

Superior antitumoral activity of dimerized targeted single-chain TRAIL fusion proteins under retention of tumor selectivity
por: Siegemund, M, et al.
Publicado: (2012)

Lambertianic Acid Sensitizes Non-Small Cell Lung Cancers to TRAIL-Induced Apoptosis via Inhibition of XIAP/NF-κB and Activation of Caspases and Death Receptor 4
por: Ahn, Deok Soo, et al.
Publicado: (2018)

Marine Actinomycetes-Derived Secondary Metabolites Overcome TRAIL-Resistance via the Intrinsic Pathway through Downregulation of Survivin and XIAP
por: Elmallah, Mohammed I. Y., et al.
Publicado: (2020)

The long noncoding RNA XIAP-AS1 promotes XIAP transcription by XIAP-AS1 interacting with Sp1 in gastric cancer cells
por: Cai, Jun, et al.
Publicado: (2017)

Bortezomib sensitises TRAIL-resistant HPV-positive head and neck cancer cells to TRAIL through a caspase-dependent, E6-independent mechanism
por: Bullenkamp, J, et al.
Publicado: (2014)

Head-to-Head Comparison of BRAF/MEK Inhibitor Combinations Proposes Superiority of Encorafenib Plus Trametinib in Melanoma
por: Schulz, Alexander, et al.
Publicado: (2022)

Countering TRAIL Resistance in Melanoma
por: Eberle, Jürgen
Publicado: (2019)

Prognostic significance of XIAP and NF-κB expression in esophageal carcinoma with postoperative radiotherapy
por: Zhou, Suna, et al.
Publicado: (2013)

Low-Level Endothelial TRAIL-Receptor Expression Obstructs the CNS-Delivery of Angiopep-2 Functionalised TRAIL-Receptor Agonists for the Treatment of Glioblastoma
por: Krishna Moorthy, Nivetha, et al.
Publicado: (2021)

Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells
por: Margue, Christiane, et al.
Publicado: (2019)

XIAP’s Profile in Human Cancer
por: Tu, Huailu, et al.
Publicado: (2020)

Overcoming resistance to BRAF inhibition in BRAF-mutated metastatic melanoma
por: Spagnolo, Francesco, et al.
Publicado: (2014)

Targeting BRAF for patients with melanoma
por: Arkenau, H-T, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_6809319mn4sg8q5k6m9g2498e7